-
Analysis of the Current Clinical Research Management System of Investigator Initiated Trials in China
Ye Cao, Xin Wang, Yu Cao, Fuyu Song, Silvia Minelli, Jibin Li, Kexin Li, Minghuang Hong
Research Paper: Clinical Investigation
-
Analysis of the Current Clinical Research Management System of Investigator Initiated Trials in China
Ye Cao, Xin Wang, Yu Cao, Fuyu Song, Silvia Minelli, Jibin Li, Kexin Li, Minghuang Hong
Research Paper: Clinical Investigation
-
Analysis of the Current Clinical Research Management System of Investigator Initiated Trials in China
Ye Cao, Xin Wang, Yu Cao, Fuyu Song, Silvia Minelli, Jibin Li, Kexin Li, Minghuang Hong
Research Paper: Clinical Investigation
-
Analysis of the Current Clinical Research Management System of Investigator Initiated Trials in China
Ye Cao, Xin Wang, Yu Cao, Fuyu Song, Silvia Minelli, Jibin Li, Kexin Li, Minghuang Hong
Research Paper: Clinical Investigation
-
Analysis of the Current Clinical Research Management System of Investigator Initiated Trials in China
Ye Cao, Xin Wang, Yu Cao, Fuyu Song, Silvia Minelli, Jibin Li, Kexin Li, Minghuang Hong
Research Paper: Clinical Investigation
-
Analysis of the Current Clinical Research Management System of Investigator Initiated Trials in China
Ye Cao, Xin Wang, Yu Cao, Fuyu Song, Silvia Minelli, Jibin Li, Kexin Li, Minghuang Hong
Research Paper: Clinical Investigation
-
Omalizumab for the treatment of atopic dermatitis
Ibon Eguiluz-Gracia, Teresa Robledo-Echarren, Ricardo Suarez-Fernandez, Montserrat Fernandez-Rivas & Silvia Sanchez Ramon
Drug Evaluation: Clinical Investigation
-
Omalizumab for the treatment of atopic dermatitis
Ibon Eguiluz-Gracia, Teresa Robledo-Echarren, Ricardo Suarez-Fernandez, Montserrat Fernandez-Rivas & Silvia Sanchez Ramon
Drug Evaluation: Clinical Investigation
-
Omalizumab for the treatment of atopic dermatitis
Ibon Eguiluz-Gracia, Teresa Robledo-Echarren, Ricardo Suarez-Fernandez, Montserrat Fernandez-Rivas & Silvia Sanchez Ramon
Drug Evaluation: Clinical Investigation
-
Omalizumab for the treatment of atopic dermatitis
Ibon Eguiluz-Gracia, Teresa Robledo-Echarren, Ricardo Suarez-Fernandez, Montserrat Fernandez-Rivas & Silvia Sanchez Ramon
Drug Evaluation: Clinical Investigation
-
Omalizumab for the treatment of atopic dermatitis
Ibon Eguiluz-Gracia, Teresa Robledo-Echarren, Ricardo Suarez-Fernandez, Montserrat Fernandez-Rivas & Silvia Sanchez Ramon
Drug Evaluation: Clinical Investigation
-
Omalizumab for the treatment of atopic dermatitis
Ibon Eguiluz-Gracia, Teresa Robledo-Echarren, Ricardo Suarez-Fernandez, Montserrat Fernandez-Rivas & Silvia Sanchez Ramon
Drug Evaluation: Clinical Investigation
-
Ecallantide for the treatment of acute attacks of hereditary angioedema due to C1-inhibitor deficiency
Jonathan Bernstein, Joseph Biedenkapp
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ecallantide for the treatment of acute attacks of hereditary angioedema due to C1-inhibitor deficiency
Jonathan Bernstein, Joseph Biedenkapp
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ecallantide for the treatment of acute attacks of hereditary angioedema due to C1-inhibitor deficiency
Jonathan Bernstein, Joseph Biedenkapp
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ecallantide for the treatment of acute attacks of hereditary angioedema due to C1-inhibitor deficiency
Jonathan Bernstein, Joseph Biedenkapp
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ecallantide for the treatment of acute attacks of hereditary angioedema due to C1-inhibitor deficiency
Jonathan Bernstein, Joseph Biedenkapp
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ecallantide for the treatment of acute attacks of hereditary angioedema due to C1-inhibitor deficiency
Jonathan Bernstein, Joseph Biedenkapp
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical trial identifies potential new treatments for infantile eczema
News and Views: Clinical Investigation
-
Clinical trial identifies potential new treatments for infantile eczema
News and Views: Clinical Investigation
-
Clinical trial identifies potential new treatments for infantile eczema
News and Views: Clinical Investigation
-
Clinical trial identifies potential new treatments for infantile eczema
News and Views: Clinical Investigation
-
Clinical trial identifies potential new treatments for infantile eczema
News and Views: Clinical Investigation
-
Clinical trial identifies potential new treatments for infantile eczema
News and Views: Clinical Investigation
-
Crizotinib for the treatment of non-small-cell lung cancer with ALK gene rearrangements
Muhammad Alamgeer, Toni-Maree Rogers, Stephen B Fox, Benjamin Solomon
Review: Clinical Trail Outcomes: Clinical Investigation
-
Crizotinib for the treatment of non-small-cell lung cancer with ALK gene rearrangements
Muhammad Alamgeer, Toni-Maree Rogers, Stephen B Fox, Benjamin Solomon
Review: Clinical Trail Outcomes: Clinical Investigation
-
Crizotinib for the treatment of non-small-cell lung cancer with ALK gene rearrangements
Muhammad Alamgeer, Toni-Maree Rogers, Stephen B Fox, Benjamin Solomon
Review: Clinical Trail Outcomes: Clinical Investigation
-
Crizotinib for the treatment of non-small-cell lung cancer with ALK gene rearrangements
Muhammad Alamgeer, Toni-Maree Rogers, Stephen B Fox, Benjamin Solomon
Review: Clinical Trail Outcomes: Clinical Investigation
-
Crizotinib for the treatment of non-small-cell lung cancer with ALK gene rearrangements
Muhammad Alamgeer, Toni-Maree Rogers, Stephen B Fox, Benjamin Solomon
Review: Clinical Trail Outcomes: Clinical Investigation
-
Crizotinib for the treatment of non-small-cell lung cancer with ALK gene rearrangements
Muhammad Alamgeer, Toni-Maree Rogers, Stephen B Fox, Benjamin Solomon
Review: Clinical Trail Outcomes: Clinical Investigation
-
Lacosamide as a new add-on therapy for the treatment of partial-onset seizures
Steve S Chung
Review Article: Clinical Investigation
-
Lacosamide as a new add-on therapy for the treatment of partial-onset seizures
Steve S Chung
Review Article: Clinical Investigation
-
Lacosamide as a new add-on therapy for the treatment of partial-onset seizures
Steve S Chung
Review Article: Clinical Investigation
-
Lacosamide as a new add-on therapy for the treatment of partial-onset seizures
Steve S Chung
Review Article: Clinical Investigation
-
Lacosamide as a new add-on therapy for the treatment of partial-onset seizures
Steve S Chung
Review Article: Clinical Investigation
-
Lacosamide as a new add-on therapy for the treatment of partial-onset seizures
Steve S Chung
Review Article: Clinical Investigation